Dosage, plasms concentration and antiarrhythmic effect of procainamide in sustained-release tablets. - Suppr | 超能文献

Dosage, plasms concentration and antiarrhythmic effect of procainamide in sustained-release tablets.

作者信息

Arstila M, Katila M, Sundquist H, Anttila M, Pere E, Tikkanen R

出版信息

Acta Med Scand. 1974 Mar;195(3):217-22. doi: 10.1111/j.0954-6820.1974.tb08125.x.

DOI:10.1111/j.0954-6820.1974.tb08125.x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Dosage, plasms concentration and antiarrhythmic effect of procainamide in sustained-release tablets.

Acta Med Scand. 1974 Mar;195(3):217-22. doi: 10.1111/j.0954-6820.1974.tb08125.x.

2

A new sustained-release tablet formulation of procainamide.

Eur J Clin Pharmacol. 1973 Dec;6(4):251-5. doi: 10.1007/BF00644741.

3

Plasma levels of procaine amide after administration of conventional and sustained-release tablets.

Eur J Clin Pharmacol. 1973 Dec;6(4):245-50. doi: 10.1007/BF00644740.

4

Experiences on a sustained-release procainamide preparation.关于一种普鲁卡因胺缓释制剂的经验。

Curr Ther Res Clin Exp. 1973 Oct;15(10):707-12.

5

[Serum concentrations of procainamide during treatment with ordinary and sustained-release tablets].

Ugeskr Laeger. 1976 Sep 27;138(40):2433-7.

6

[Oral administration of procainamide for ventricular arrhythmia. Plasma concentrations during use of tablets(Pronestyl) and a slow-release preparation (Porcainamide Durettes)].[口服普鲁卡因胺治疗室性心律失常。使用片剂（普罗奈斯特）和缓释制剂（普鲁卡因胺长效片）期间的血浆浓度]

Ugeskr Laeger. 1976 Sep 27;138(40):2425-33.

7

Immediate-release and sustained-release procainamide: bioavailability at steady state in cardiac patients.速释和缓释普鲁卡因酰胺：心脏病患者稳态时的生物利用度

Ann Intern Med. 1983 May;98(5 Pt 1):613-4. doi: 10.7326/0003-4819-98-5-613.

8

Pharmacokinetic of procainamide in man.普鲁卡因酰胺在人体中的药代动力学。

Ann N Y Acad Sci. 1971 Jul 6;179:370-82. doi: 10.1111/j.1749-6632.1971.tb46914.x.

9

Procainamide acetylation and disposition in dialysis patients.透析患者中普鲁卡因胺的乙酰化作用及处置情况

Clin Invest Med. 1979;2(1):5-11.

10

The assessment of an antiarrhythmic agent, sustained-release procainamide, with the aid of Holter monitoring.借助动态心电图监测对抗心律失常药物缓释普鲁卡因胺进行评估。

Med J Aust. 1977 Nov 26;2(22):733-5. doi: 10.5694/j.1326-5377.1977.tb99253.x.

引用本文的文献

1

Procainamide and phenytoin. Comparative study of their antiarrhythmic effects at apparent therapeutic plasma levels.普鲁卡因胺和苯妥英钠。在表观治疗血浆水平下它们抗心律失常作用的比较研究。

Br Heart J. 1975 Jul;37(7):731-40. doi: 10.1136/hrt.37.7.731.

2

Serum procainamide levels as therapeutic guides.作为治疗指导的血清普鲁卡因胺水平。

Clin Pharmacokinet. 1977 Nov-Dec;2(6):389-402. doi: 10.2165/00003088-197702060-00001.

3

Clinical pharmacokinetics of procainamide.普鲁卡因胺的临床药代动力学。

Clin Pharmacokinet. 1978 Mar-Apr;3(2):97-107. doi: 10.2165/00003088-197803020-00001.